Answer
Daratumumab targets CD38, a protein expressed at high levels on the surface of multiple myeloma tumour cells and at various levels on other cell types and tissues.
Sources for this answer
- DARZALEX 20 mg/mL concentrate for solution for infusionJanssen-Cilag Ltd (a Johnson & Johnson Company) · emc · SmPC §5.1 Pharmacodynamic properties · Version 36Document updated
Sources checked